Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-07-02 @ 9:08 AM
Study NCT ID:
NCT00176605
Status:
COMPLETED
Last Update Posted:
2014-05-20
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Sponsor:
Rutgers, The State University of New Jersey
Organization: